Viewing StudyNCT03215511



Ignite Creation Date: 2024-05-06 @ 10:16 AM
Last Modification Date: 2024-10-26 @ 12:27 PM
Study NCT ID: NCT03215511
Status: COMPLETED
Last Update Posted: 2024-03-26
First Post: 2017-06-30

Brief Title: A Study to Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer
Sponsor: Bayer
Organization: Bayer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-07-03
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-11
Primary Completion Date Type: ACTUAL
Completion Date: 2023-01-30
Completion Date Type: ACTUAL
First Submit Date: 2017-06-30
First Submit QC Date: July 10 2017
Study First Post Date: 2017-07-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-25
Last Update Post Date: 2024-03-26
Last Update Post Date Type: ACTUAL